| Schedule of respective information by segment |
For the six months ended June 30, 2026 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | CD-19 | | GDT cell | | Corporate | | | | | | Exosome | | Armed-T | | therapy | | and | | | | | | Products | | Products | | Products | | Unallocated | | Total | Revenue | | $ | 1,386,608 | | $ | — | | $ | — | | $ | — | | $ | 1,386,608 | Cost of revenue | | | (829,124) | | | — | | | — | | | — | | | (829,124) | Gross profit | | | 557,484 | | | — | | | — | | | — | | | 557,484 | Operating expenses | | | 367,989 | | | 128,536 | | | 1,251,462 | | | 971,674 | | | 2,719,661 | Operating profit (loss) | | | 189,495 | | | (128,536) | | | (1,251,462) | | | (971,674) | | | (2,162,177) | Other income (expenses), net | | | (28) | | | — | | | — | | | — | | | (28) | Profit (loss) before income tax | | | 189,467 | | | (128,536) | | | (1,251,462) | | | (971,674) | | | (2,162,205) | | | | | | | | | | | | | | | | | As of June 30, 2026 | | | | | | | | | | | | | | | | Identifiable long-lived assets | | | 10,746 | | | — | | | — | | | 149,180 | | | 159,926 | Total assets | | | 695,816 | | | — | | | — | | | 8,215,322 | | | 8,911,138 |
For the six months ended June 30, 2025: | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | CD-19 | | GDT cell | | Corporate | | | | | | Exosome | | Armed-T | | therapy | | and | | | | | | Products | | Products | | Products | | Unallocated | | Total | Revenue | | $ | 1,129,238 | | $ | — | | $ | — | | $ | — | | $ | 1,129,238 | Cost of revenue | | | (740,172) | | | — | | | — | | | — | | | (740,172) | Gross profit | | | 389,066 | | | — | | | — | | | — | | | 389,066 | Operating expenses | | | 345,929 | | | 357,468 | | | 509,554 | | | 785,857 | | | 1,998,808 | Operating income (loss) | | | 43,137 | | | (357,468) | | | (509,554) | | | (785,857) | | | (1,609,742) | Other income (expenses), net | | | (10,186) | | | — | | | — | | | 17,835 | | | 7,649 | Profit (loss) before income tax | | | 32,951 | | | (357,468) | | | (509,554) | | | (768,022) | | | (1,602,093) | | | | | | | | | | | | | | | | | As of June 30, 2025 | | | | | | | | | | | | | | | | Identifiable long-lived assets | | | 18,194 | | | — | | | — | | | 648,831 | | | 667,025 | Total assets | | | 4,202,757 | | | — | | | — | | | 1,588,821 | | | 5,791,578 |
|